Viewing Study NCT05616494


Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2026-03-13 @ 12:16 PM
Study NCT ID: NCT05616494
Status: UNKNOWN
Last Update Posted: 2023-03-22
First Post: 2022-11-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module